Science Explorer Back to mapMap
Discussion
Researcher · Radboud University Nijmegen · Netherlands

Theo van Voorthuizen

Theo van Voorthuizen publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies and Esophageal Cancer Research and Treatment.

ORCID 0000-0002-2844-4338 OpenAlex
World rank
#1,685,729
of 7,710,434 ranked researchers
Rank in Netherlands
#37,438
of 107,149
Works
54
Citations
1.1k
Citations per work
20.9
h-index
17
i10-index 27Top 30% in Oncology
Theo van Voorthuizen

What does Theo van Voorthuizen research?

Theo van Voorthuizen's work is mostly in Medicine (70%), Biochemistry, Genetics and Molecular Biology (4%).

Health Sciences: 38 works · 70.0% of their workMedicine: 38 works · 70.0% of their workOncology: 14 works · 25.3% of their workPulmonary and Respiratory Medicine: 10 works · 18.8% of their workSurgery: 9 works · 16.2% of their workPublic Health, Environmental and Occupational Health: 3 works · 5.2% of their workPathology and Forensic Medicine: 2 works · 4.5% of their workEverything else: 14 works · 25.5% of their workLife Sciences: 2 works · 4.5% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 4.5% of their workCancer Research: 2 works · 4.5% of their workTHEIR WORKTheo vanVoorthuizen54works
Life Sciences4%Health Sciences70%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3870.0%
  2. Everything else1425.5%
    1. Biochemistry, Genetics and Molecular Biology24.5%
  1. 1Oncology25% of their works
  2. 2Pulmonary and Respiratory Medicine19% of their works
  3. 3Surgery16% of their works
  4. 4Public Health, Environmental and Occupational Health5% of their works
  5. 5Pathology and Forensic Medicine4% of their works
  6. 6Cancer Research4% of their works

Research topics

Which keywords describe Theo van Voorthuizen's research?

The keywords of their largest research topics: Chemotherapy, Endoscopic Resection, Clinical Practice Guidelines, Gastric Cancer, Molecular Characterization, Cetuximab, KRAS Mutations and Esophageal Carcinoma.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Chemotherapy262 topics
  2. Endoscopic Resection232 topics
  3. Clinical Practice Guidelines182 topics
  4. Gastric Cancer141 topic
  5. Molecular Characterization141 topic
  6. Cetuximab121 topic
  7. KRAS Mutations121 topic
  8. Esophageal Carcinoma91 topic
  9. Preoperative Chemoradiotherapy91 topic
  10. Quality of Life82 topics
  11. Cancer Genomics51 topic
  12. Mutational Signatures51 topic
  13. Cancer Survivorship41 topic
  14. Chemotherapy-Induced Peripheral Neuropathy41 topic
  15. Hepatocellular Carcinoma41 topic
  16. Immune Checkpoint Blockade41 topic
  17. Liver Cancer41 topic
  18. PD-1 and PD-L141 topic
  19. Patient-Reported Outcomes41 topic
  20. Taxanes41 topic

Where does Theo van Voorthuizen work?

Theo van Voorthuizen's main affiliation in the publication record is Radboud University Nijmegen, Netherlands.

How many publications and citations does Theo van Voorthuizen have?

OpenAlex counts 54 works and 1,130 citations for Theo van Voorthuizen, an h-index of 17, ranking #1,685,729 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Theo van Voorthuizen. Posts are plain text and can be reported.